AstraZeneca Pharmaceuticals 00310009530 - … | USA MedPremium
Daliresp Roflumilast 500 mcg Tablets - Chronic COPD Treatment
USAMP#73116234SKU: 00310009530Daliresp®
License Required
Product Spotlight
Contains Roflumilast 500 mcg, a potent Phosphodiesterase Type 4 Inhibitor, designed to treat symptoms of chronic obstructive pulmonary disease (COPD).
Manufactured by AstraZeneca Pharmaceuticals, ensuring high-quality and reliable medication for COPD management.
Each bottle contains 30 tablets, specifically formulated for oral administration.
Prescription medication that targets the underlying inflammation in the lungs, improving lung function and reducing exacerbations in severe COPD patients.
Latex-free product, suitable for patients with latex allergies.
Ensure to store in a cool, dry place to maintain efficacy and shelf-life.
